Life Sciences And Automation Companies Deliver The Future—Together

By Todd Walden, Nathan Pettus, Chris Darrell, and Peter Dam Madsen, Emerson

Speed is no longer a competitive edge in life sciences—it’s a mandate. The COVID-19 vaccine pipeline proved that accelerated development is not only possible but scalable. Yet one persistent challenge remains: technology transfer. As pharmaceutical manufacturers adopt automation and digital tools to streamline production, the ability to transfer data and processes efficiently across teams and sites becomes critical. Leaders from Emerson, Bristol Myers Squibb, and FUJIFILM Diosynth Biotechnologies are tackling this head-on through strategic collaboration. Their shared goal? To remove friction from the transfer process and bring treatments to patients faster than ever before.

Explore how cross-industry partnerships are reshaping the future of biopharma manufacturing—and why collaboration may be the most powerful tool in the race to market.